205 related articles for article (PubMed ID: 38525091)
1. Roles of Pharmacists in the Management of Sickle Cell Disease in Adults: A Narrative Review.
Weaver SB; Nonyel NP; Rungkitwattanakul D
J Pharm Technol; 2024 Apr; 40(2):92-99. PubMed ID: 38525091
[No Abstract] [Full Text] [Related]
2. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
3. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
6. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
8. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
[TBL] [Abstract][Full Text] [Related]
10. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
[TBL] [Abstract][Full Text] [Related]
11. Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review.
Kakkar M; Holderle K; Sheth M; Arany S; Schiff L; Planerova A
Anemia; 2021; 2021():5556708. PubMed ID: 34721900
[TBL] [Abstract][Full Text] [Related]
12. Pain Management Issues as Part of the Comprehensive Care of Patients with Sickle Cell Disease.
Lakkakula BVKS; Sahoo R; Verma H; Lakkakula S
Pain Manag Nurs; 2018 Dec; 19(6):558-572. PubMed ID: 30076112
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
14. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
[TBL] [Abstract][Full Text] [Related]
15. A rapid evidence assessment of sickle cell disease educational interventions.
Oti AE; Heyes K; Bruce F; Wilmott D
J Clin Nurs; 2023 Mar; 32(5-6):812-824. PubMed ID: 35590440
[TBL] [Abstract][Full Text] [Related]
16. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell disease pain management in adolescents: a literature review.
Wilson BH; Nelson J
Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
20. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
Peterson EE; Salemi JL; Dongarwar D; Salihu HM
Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
